https://geneonline.news/莫德納第三季業績超預期，但呼吸道融合病毒疫苗/2024-11-07T23:44:48.000Zweekly0.8 https://geneonline.news/莫德納第三季業績超預期-rsv疫苗銷售卻低於預期/2024-11-07T23:38:48.000Zweekly0.8 https://geneonline.news/ai-醫療革命來臨，倫理挑戰準備好了嗎？/2024-11-07T23:10:03.000Zweekly0.8 https://geneonline.news/維斯樂特生治療失效-薩瑞普塔最新肌肉萎縮症藥物/2024-11-07T22:56:50.000Zweekly0.8 https://geneonline.news/ai-應用前景與挑戰：德納圖爾節目探討/2024-11-07T22:32:47.000Zweekly0.8 https://geneonline.news/孕期關懷：以信任建立會員長期忠誠度/2024-11-07T22:19:00.000Zweekly0.8 https://geneonline.news/梯瓦藥廠仿製藥業務第三季強勁成長，美國銷售額/2024-11-07T21:44:49.000Zweekly0.8 https://geneonline.news/steriline-asia-將參加-cphi-pmec-印度展，展示最新技術和製程進展/2024-11-07T21:29:25.000Zweekly0.8 https://geneonline.news/吉利德第三季表現穩健，hiv業務持續強勁/2024-11-07T21:16:47.000Zweekly0.8 https://geneonline.news/biospace-數據顯示：職缺減少競爭加劇/2024-11-07T20:00:47.000Zweekly0.8 https://geneonline.news/pumasai-推出-askpumas-和-deeppumas，革新藥物動力學和臨床藥理學/2024-11-07T15:34:24.000Zweekly0.8 https://geneonline.news/川普勝選引發精神衛生界憂喜參半/2024-11-07T12:09:03.000Zweekly0.8 https://geneonline.news/antibody-drug-complex-not-only-connects-drugs-and-cancer-cells-but-also-leads-to-billions-of-dollars-in-business-opportunities/2024-11-29T16:26:42.000Zweekly0.8 https://geneonline.news/心理健康專家對行為健康去污名化、ai-應用等領域/2024-11-07T11:40:02.000Zweekly0.8 https://geneonline.news/fda-roundup-november-5-2024/2024-11-15T21:41:14.000Zweekly0.8 https://geneonline.news/acadia-製藥以-1-5-億美元出售優先審查憑證，買家未公開/2024-11-07T06:49:01.000Zweekly0.8 https://geneonline.news/生技製藥裁員潮持續：biospace-跟踪最新動態/2024-11-07T10:53:21.000Zweekly0.8 https://geneonline.news/諾和諾德第三季營收不及預期，但減肥藥銷售超預/2024-11-06T23:15:48.000Zweekly0.8 https://geneonline.news/女兒驚險機程啟發領導者：醫療需追求零失誤率/2024-11-06T23:12:02.000Zweekly0.8 https://geneonline.news/川普勝選引發分析師褒貶不一-反壟斷法放鬆利好併/2024-11-06T23:00:49.000Zweekly0.8 https://geneonline.news/生技併購與ipo活動回升-專家分享價值最大化和退出/2024-11-06T22:24:46.000Zweekly0.8 https://geneonline.news/生技併購及-ipo-活動回升-專家解析如何最大化價值和/2024-11-06T22:21:47.000Zweekly0.8 https://geneonline.news/整合照護團隊-擴展社區計畫-改善健康照護體系/2024-11-06T22:16:03.000Zweekly0.8 https://geneonline.news/凱特蘭第一季業績遜於預期-收購案面臨阻力/2024-11-06T21:48:48.000Zweekly0.8 https://geneonline.news/truist-分析師：anito-cel-安全性或成區隔多發性骨髓瘤-car-t-療法/2024-11-06T21:32:49.000Zweekly0.8 https://geneonline.news/禮來藥廠業績意外下滑，諾和諾德wegovy藥物取得重大/2024-11-06T20:08:52.000Zweekly0.8 https://geneonline.news/約翰霍普金斯大學生物醫學工程學系設計團隊課程/2024-11-06T19:12:49.000Zweekly0.8 https://geneonline.news/the-beginning-of-the-great-era-of-african-manufacturing-biontech-mrna-vaccine-manufacturing-plant/2024-11-06T17:52:49.000Zweekly0.8 https://geneonline.news/koreas-bio-health-new-market-creation-strategy-4-policy-infrastructure/2024-11-06T17:02:47.000Zweekly0.8 https://geneonline.news/interview-japan-bioindustry-association-yoshiaki-tsukamoto/2024-11-29T16:26:22.000Zweekly0.8 https://geneonline.news/細胞療法公司面臨募資困境-調整人事配置迎戰自體/2024-11-06T14:08:32.000Zweekly0.8 https://geneonline.news/瑞基恩第三季高劑量eylea注射液表現遜色，分析師對/2024-11-06T11:08:41.000Zweekly0.8 https://geneonline.news/諾和諾德減肥藥wegovy-臨床試驗顯示改善非酒精性脂肪/2024-11-06T11:08:41.000Zweekly0.8 https://geneonline.news/禮來ceo承認公司受批發商庫存決策影響/2024-11-06T11:08:41.000Zweekly0.8 https://geneonline.news/免疫療法熱潮降溫-小型生物科技公司研發下一代癌/2024-11-06T11:08:40.000Zweekly0.8 https://geneonline.news/多家生物製藥公司放棄阿茲海默症和帕金森症項目-2/2024-11-06T11:08:40.000Zweekly0.8 https://geneonline.news/藥廠向法院提訴求，要求重新審視《通膨削減法案/2024-11-06T11:08:40.000Zweekly0.8 https://geneonline.news/維京治療vk2735減肥藥臨床試驗超預期，患者體重減輕8-2/2024-11-06T11:08:39.000Zweekly0.8 https://geneonline.news/fda將在兩周內審核四種潛在療法，包括治療急性淋/2024-11-06T11:08:39.000Zweekly0.8 https://geneonline.news/抗癌療法轉向-自體免疫疾病新希望/2024-11-06T11:08:38.000Zweekly0.8 https://geneonline.news/vertex-製藥第三季業績強勁，多項重要里程碑即將到來/2024-11-06T11:08:38.000Zweekly0.8 https://geneonline.news/fda-2023-藥品審批大揭秘：55-個新藥，34-個細胞與基因療法/2024-11-06T11:08:38.000Zweekly0.8 https://geneonline.news/biontech-第三季獲利超預期-首次單季獲利-但下修全年展望/2024-11-06T11:08:37.000Zweekly0.8 https://geneonline.news/諾和諾德斥資2-85億美元與-ascendis-合作-開發新型-glp-1-藥物/2024-11-06T11:08:37.000Zweekly0.8 https://geneonline.news/海拉細胞案：諾華與維特里斯面臨道德與法律挑戰/2024-11-06T11:08:37.000Zweekly0.8 https://geneonline.news/阿斯利康減肥藥物取得進展-三項早期藥物進入二期/2024-11-06T11:08:36.000Zweekly0.8 https://geneonline.news/生命科學博士畢業後的12種非實驗室職涯選擇/2024-11-06T11:08:36.000Zweekly0.8 https://geneonline.news/默沙東zenocutuzumab獲批日期延後三個月-分析師：不影響獲/2024-11-06T11:08:36.000Zweekly0.8 https://geneonline.news/再生醫學公司-sana-生物科技裁員，加大糖尿病治療項/2024-11-06T11:08:36.000Zweekly0.8 https://geneonline.news/beam-101-治療鐮刀型細胞貧血有競爭力，但患者死亡事件/2024-11-06T11:08:35.000Zweekly0.8 https://geneonline.news/生技藥業裁員潮持續-biospace為您追踪最新動態/2024-11-06T15:22:36.000Zweekly0.8 https://geneonline.news/多家生物製藥公司放棄阿茲海默症和帕金森症項目/2024-11-06T11:01:20.000Zweekly0.8 https://geneonline.news/koreas-bio-health-new-market-creation-strategy-3-strengthen-the-research-and-development-of-advanced-composite-technologies/2024-11-06T16:49:30.000Zweekly0.8 https://geneonline.news/space-rd-purposes-of-proton-therapy-ntuh-national-space-center-memorandum/2024-11-05T16:36:27.000Zweekly0.8 https://geneonline.news/koreas-bio-health-new-market-creation-strategy-2-activating-bio-health-industry-exports/2024-11-06T16:38:22.000Zweekly0.8 https://geneonline.news/the-60th-fapa-was-held-in-south-korea-two-pharmacists-from-taiwan-won-awards/2024-11-05T14:27:27.000Zweekly0.8 https://geneonline.news/interview-japan-pharmaceutical-manufacturers-association-hiroaki-ueno/2024-11-14T13:46:06.000Zweekly0.8 https://geneonline.news/2024-us-president-election-impact-on-biopharma-industry/2024-11-15T21:41:10.000Zweekly0.8 https://geneonline.news/pharmaessentia-applies-for-phase-i-clinical-trial-of-t-cell-receptor-immunotherapy/2024-11-04T16:46:50.000Zweekly0.8 https://geneonline.news/koreas-bio-health-new-market-creation-strategy-1-data-driven-innovation-in-medical-health-and-care-services/2024-11-06T16:38:17.000Zweekly0.8 https://geneonline.news/germany-released-a-new-strategy-to-assist-the-pharmaceutical-industry-in-strengthening-research-and-stabilizing-production-and-supply/2024-11-04T15:24:14.000Zweekly0.8 https://geneonline.news/china-2024-q1-q3-china-pharmaceutical-transaction-market-insights-license-in-license-out-transaction-trend-reversal-ma-and-the-rise-of-the-newco-model/2024-11-15T21:40:59.000Zweekly0.8 https://geneonline.news/strengthening-biotech-ties-highlights-from-the-bioconnect-forum-and-future-collaboration-between-taiwan-and-australia/2024-11-29T16:26:48.000Zweekly0.8 https://geneonline.news/2024-australia-market-report-summary/2024-11-15T21:40:51.000Zweekly0.8 https://geneonline.news/key-trends-in-the-pharmaceutical-landscape-for-2024-part-1/2024-11-15T21:40:42.000Zweekly0.8 https://geneonline.news/bpipo-dcb-nvidia-gen-ai-in-healthcare/2026-01-26T14:01:38.000Zweekly0.8 https://geneonline.news/anya-biopharm-emerging-stock-market/2024-11-12T09:39:57.000Zweekly0.8 https://geneonline.news/novartis-諾華制藥法律挑戰失利：心臟藥物仿製藥仍繼續/2024-10-24T11:26:35.000Zweekly0.8 https://geneonline.news/tfbs-bioscience-north-hsinchu-viral-vector-cdmo/2024-11-12T09:39:50.000Zweekly0.8 https://geneonline.news/ams-bioteq-2024-medical-japan/2024-11-12T09:39:32.000Zweekly0.8 https://geneonline.news/australia-biotech-and-pharma-industry/2024-11-14T17:33:51.000Zweekly0.8 https://geneonline.news/nucleate-taiwan-2024-ai-trend/2024-11-12T09:39:24.000Zweekly0.8 https://geneonline.news/japanese-pharmaceuticals-introduction/2024-11-21T16:57:00.000Zweekly0.8 https://geneonline.news/regimmune-kiji-therapeutics-binding-term-sheet/2024-10-22T17:59:51.000Zweekly0.8 https://geneonline.news/prospects-and-challenges-for-taiwans-biotech-capital-market-from-startup-funding-to-ipo/2024-11-05T11:41:09.000Zweekly0.8 https://geneonline.news/post-pandemic-precision-medicine-and-sdgs/2024-11-05T11:41:04.000Zweekly0.8 https://geneonline.news/sartorius-downstream-perspective-process-intensification/2024-11-12T09:38:44.000Zweekly0.8 https://geneonline.news/geneonline-biodnd-google-cloud-platform/2024-11-29T16:26:54.000Zweekly0.8 https://geneonline.news/japanese-korea-venture-opportunity-and-challenge/2024-11-05T11:40:16.000Zweekly0.8 https://geneonline.news/2024-taiwan-bio-industry-organization/2024-10-23T10:43:06.000Zweekly0.8 https://geneonline.news/illumina-miseq-i100-series-first-global-launch/2024-11-05T11:40:56.000Zweekly0.8 https://geneonline.news/biojapan2024-regenerative-medicine-gene-therapy-meti/2024-11-05T11:40:53.000Zweekly0.8 https://geneonline.news/japanese-regenerative-medicine-cdmo-trends/2024-11-05T11:41:17.000Zweekly0.8 https://geneonline.news/2024-nobel-prize-chemistry/2024-11-05T11:40:42.000Zweekly0.8 https://geneonline.news/biojapan2024-longevity-wonderland/2024-11-05T11:39:30.000Zweekly0.8 https://geneonline.news/biojapan2024-iain-foulkes-cancer-research-uk/2024-10-25T16:21:05.000Zweekly0.8 https://geneonline.news/biojapan2024-jpma-hiroaki-ueno/2024-11-05T11:40:39.000Zweekly0.8 https://geneonline.news/biojapan2024-tomoki-todo-oncolytic-virus-therapy/2024-10-25T16:21:18.000Zweekly0.8 https://geneonline.news/biojapan_2024_opening_ceremony/2024-10-25T16:20:57.000Zweekly0.8 https://geneonline.news/dcb_bpipo_biojapan-2024-taiwan-delegation/2026-01-26T13:38:39.000Zweekly0.8 https://geneonline.news/2024109-bora-app13007/2024-10-25T16:20:46.000Zweekly0.8 https://geneonline.news/premier-biotech-收購-desert-tox，創新藥物檢測獲fda批准/2024-10-09T11:56:02.000Zweekly0.8 https://geneonline.news/scholar-rock-脊髓性肌肉萎縮症藥物試驗成功，股價飆漲。/2024-10-09T11:46:20.000Zweekly0.8 https://geneonline.news/溶瘤病毒療法-oncolytics-biotech-擬向fda申請快速審批/2024-10-09T09:27:00.000Zweekly0.8 https://geneonline.news/20241008-mirna-nobel-prize-in-physiology-or-medicine/2024-10-23T14:43:33.000Zweekly0.8 https://geneonline.news/1007-3ai-center-mohw/2024-10-23T14:43:40.000Zweekly0.8 https://geneonline.news/1007-linbioscience-lbs007-fda/2024-10-23T14:45:21.000Zweekly0.8 https://geneonline.news/流感疫苗-鼻噴劑-過fda/2024-10-07T11:35:33.000Zweekly0.8 https://geneonline.news/20241005-pharmaessentia-ropeg/2024-10-23T14:44:23.000Zweekly0.8 https://geneonline.news/20241004-dcb-eno-1-astro-hul001/2024-10-23T14:45:29.000Zweekly0.8